GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.14 $2.79 Thursday, 18th Apr 2024 FGEN stock ended at $1.17. This is 7.87% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 13.16% from a day low at $1.14 to a day high of $1.29.
90 days $0.760 $2.93
52 weeks $0.335 $20.52

Historical FibroGen prices

Date Open High Low Close Volume
2020-11-30 $40.20 $41.46 $39.49 $41.31 575 227
2020-11-27 $40.41 $41.24 $39.96 $40.17 379 487
2020-11-25 $41.33 $41.40 $39.84 $40.02 377 663
2020-11-24 $40.39 $42.06 $40.00 $41.33 551 213
2020-11-23 $40.75 $41.27 $40.06 $40.19 878 035
2020-11-20 $40.39 $41.15 $39.50 $40.50 534 549
2020-11-19 $41.29 $42.43 $40.57 $40.77 620 946
2020-11-18 $43.99 $44.45 $41.13 $41.53 1 139 677
2020-11-17 $42.91 $44.14 $42.05 $44.11 550 500
2020-11-16 $42.60 $43.20 $41.86 $43.08 412 642
2020-11-13 $41.43 $42.63 $41.32 $42.09 291 525
2020-11-12 $41.22 $42.00 $40.40 $41.01 327 985
2020-11-11 $41.20 $41.84 $39.36 $41.31 567 249
2020-11-10 $41.18 $41.99 $39.87 $40.84 1 684 729
2020-11-09 $42.32 $44.07 $40.73 $40.83 769 532
2020-11-06 $43.61 $43.61 $40.80 $41.28 444 547
2020-11-05 $42.62 $43.11 $40.90 $42.46 815 943
2020-11-04 $39.89 $42.93 $39.66 $41.86 588 711
2020-11-03 $39.22 $40.27 $38.95 $40.02 545 097
2020-11-02 $38.62 $39.23 $37.69 $39.20 595 310
2020-10-30 $38.54 $38.85 $37.54 $38.38 608 825
2020-10-29 $38.33 $39.30 $37.50 $39.01 453 255
2020-10-28 $38.89 $39.08 $38.17 $38.36 849 507
2020-10-27 $39.90 $40.33 $38.93 $39.12 644 083
2020-10-26 $42.38 $42.40 $39.65 $39.96 1 017 526
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT